Annual report [Section 13 and 15(d), not S-K Item 405]

STATEMENTS OF OPERATIONS

v3.26.1
STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ (1,516) $ 8,418
Asset impairment 0 3,692
General and administrative 3,948 4,135
Total operating expenses 2,432 16,245
Loss from operations (2,432) (16,245)
Other income    
Other income 0 314
Interest income, net 511 179
Total other income 511 493
Net Loss $ (1,921) $ (15,752)
Net loss per Class A common and common shares outstanding, basic $ (0.39) $ (38.57)
Net loss per Class A common and common shares outstanding, diluted $ (0.39) $ (38.57)
Weighted average number of Class A common and common shares outstanding, basic 4,908,164 609,696
Weighted average number of Class A common and common shares outstanding, diluted 4,908,164 609,696